Mink Therapeutics Inc

Biotech Stocks Healthcare Stocks

$10.97

-0.05 (-0.45%)

As of Feb 8, 2:18 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +82.0% upside

Low Target $17.96

Average Target $19.97

High Target $26.10

Current Price $10.97

Current
$10.97

Target
$19.97

$17.96 $19.97 avg $26.10

Scenario Analysis

Bear Case

$17.96

63.7%

Low target

Base Case

$19.97

+82.0%

Avg target

Bull Case

$26.10

+137.9%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$25.37

-56.8% from high

52-Week Low

$13.49

+-18.7% from low

Target vs 52W High

$19.97

-21.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%